JUNS Company Profile and Key Details

NASDAQ : JUNS

Jupiter Neurosciences

$0.17

0.0047+2.85%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Jupiter Neurosciences, Inc. (JUNS) stock surged +2.89%, trading at $0.17 on NASDAQ, up from the previous close of $0.17. The stock opened at $0.14, fluctuating between $0.14 and $0.20 in the recent session.

Stock Snapshot

0.1697

Prev. Close

6.35M

Market Cap

0.1367

Day Low

-0.65

P/E Ratio

-0.27

EPS (TTM)

N/A

Cash Flow per Share

0.14

Open

36.35M

Number of Shares

0.1999

Day High

46.59%

Free Float in %

N/A

Book Value

22.75M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 21, 2026	0.23	0.24	0.16	0.17	349.3M
Jul 20, 2026	0.18	0.18	0.16	0.17	547.75K
Jul 17, 2026	0.17	0.18	0.16	0.17	468.8K
Jul 16, 2026	0.18	0.18	0.17	0.17	355.86K
Jul 15, 2026	0.17	0.18	0.17	0.18	394.17K
Jul 14, 2026	0.18	0.18	0.17	0.18	827.63K
Jul 13, 2026	0.19	0.19	0.18	0.18	598.65K
Jul 10, 2026	0.19	0.20	0.19	0.19	641.41K
Jul 09, 2026	0.19	0.20	0.19	0.20	632.24K
Jul 08, 2026	0.21	0.21	0.18	0.19	3.12M
Jul 07, 2026	0.22	0.23	0.21	0.22	1.19M
Jul 06, 2026	0.21	0.23	0.21	0.22	971.84K
Jul 02, 2026	0.22	0.23	0.21	0.22	1.48M
Jul 01, 2026	0.22	0.22	0.21	0.22	840.62K
Jun 30, 2026	0.20	0.22	0.20	0.21	2.18M
Jun 29, 2026	0.21	0.22	0.20	0.21	3.54M
Jun 26, 2026	0.23	0.30	0.23	0.28	20.43M
Jun 25, 2026	0.24	0.25	0.22	0.24	4.1M
Jun 24, 2026	0.24	0.28	0.24	0.25	12.29M
Jun 23, 2026	0.23	0.26	0.22	0.24	4.66M

Contact Details

Jupiter, FL 33477

United States

https://jupiterneurosciences.com 561 406 6154

About Company

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.

Stock Peers

ARGX

28.55+3.37%

argenx SE$874.74 REGN

3.04+0.45%

Regeneron Pharmaceuticals, Inc.$675.19 MDGL

11.1+2.07%

Madrigal Pharmaceuticals, Inc.$546.79 UTHR

6.49+1.23%

United Therapeutics Corporation$535.83 VRTX

1.5+0.31%

Vertex Pharmaceuticals Incorporated$482.00 KRYS

-0.16-0.05%

Krystal Biotech, Inc.$339.06 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

8.11+2.61%

BeOne Medicines AG$318.69 PRAX

13.44+4.41%

Praxis Precision Medicines, Inc.$317.87 LGND

11.48+3.90%

Ligand Pharmaceuticals Incorporated$305.47

Frequently Asked Questions

What is the current Jupiter Neurosciences, Inc. (JUNS) stock price?

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) stock price is $0.17 in the last trading session. During the trading session, JUNS stock reached the peak price of $0.20 while $0.14 was the lowest point it dropped to. The percentage change in JUNS stock occurred in the recent session was 2.89% while the dollar amount for the price change in JUNS stock was $0.00.

JUNS's industry and sector of operation?

The NASDAQ listed JUNS is part of Biotechnology industry that operates in the broader Healthcare sector. Jupiter Neurosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of JUNS?

No Data

How JUNS did perform over past 52-week?

JUNS's closing price is 9.48% higher than its 52-week low of $0.14 where as its distance from 52-week high of $1.85 is -90.83%.

How many employees does JUNS have?

Number of JUNS employees currently stands at 5.

Link for JUNS official website?

Official Website of JUNS is: https://jupiterneurosciences.com

How do I contact JUNS?

JUNS could be contacted at phone 561 406 6154 and can also be accessed through its website. JUNS operates from 1001 North US HWY 1, Jupiter, FL 33477, United States.

How many shares of JUNS are traded daily?

JUNS stock volume for the day was 22.75M shares. The average number of JUNS shares traded daily for last 3 months was 13.08M.

What is the market cap of JUNS currently?

The market value of JUNS currently stands at $6.35M with its latest stock price at $0.17 and 36.35M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5
Beta	1.71
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	5
Beta	1.71
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

JUNS Company Profile and Key Details

Jupiter Neurosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Financial & Profitability Overview

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways